Viewing StudyNCT04924608



Ignite Creation Date: 2024-05-06 @ 4:15 PM
Last Modification Date: 2024-10-26 @ 2:06 PM
Study NCT ID: NCT04924608
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-25
First Post: 2021-05-14

Brief Title: Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic Inoperable Plexiform Neurofibromas
Sponsor: AstraZeneca
Organization: AstraZeneca

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-11-19
Start Date Type: ACTUAL
Primary Completion Date: 2024-08-05
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-03-17
Completion Date Type: ESTIMATED
First Submit Date: 2021-05-14
First Submit QC Date: June 7 2021
Study First Post Date: 2021-06-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-09
Last Update Post Date: 2024-06-25
Last Update Post Date Type: ACTUAL